1. Malinge S, Izraeli S, Crispino JD (2009) Insights into the manifestations, outcomes, and mechanisms of leukemogenesis in Down syndrome. Blood 113(12):2619–2628
2. Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) World Health Organization classification of tumours of haematopoietic and lymphoid tissues. IARC Press, Lyon
3. Suda J, Eguchi M, Akiyama Y, Iwama Y, Furukawa T, Sato Y, Miura Y et al (1987) Differentiation of blast cells from a Downs syndrome patient with transient myeloproliferative disorder. Blood 69(2):508–512
4. Choi JK (2008) Hematopoietic disorder in Down syndrome. Int J Clin Exp Pathol 1(5):387–395
5. Dhaded SM, Das R, Kumar P, Narang A (1996) Down’s syndrome with transient myeloproliferative disorder. Indian Pediatrics 33:964–966